San Antonio-based refiner Tesoro Corp. plans to invest US$400 mln for conducting facility upgrades to extract xylene feedstocks in its U.S. West Coast refining system, as per bizjournals.com. The US$400 million initial investment will lead to recovery to 15,000 bpd of xylene. Tesoro expects to start up its new facilities in 2017, subject to permitting and approval by regulators.
Previous News
Next News
-
5 week planned turnaround at Formosa Plastics' Texas steam cracker delayed
-
Middle Eastern import PP prices lose ground in Turkey, Egypt
-
Ineos buys shale gas licence stake in Scotland
-
JG Summit restart cracker - seeks naphtha cargo
-
Tecnicas Reunidas awarded US$1.5 bln turnkey contract as part of Malaysia's RAPID project
-
More buyers switching to acetylene based PVC in China
-
Phillips 66, Chevron Phillips to fund new petrochemical academy at Texas
-
SABIC mulls modifications in UK naphtha cracker to use shale ethane from US as feedstock
-
Samsung Heavy Industries to build world's first very large ethane carriers for Reliance
-
Nigerian President flags off US$1.5bln methanol, PP, PE, Quantum Petrochemical Complex
-
Samvardhana Motherson International Limited India’s Global Automotive Plastics & Systems Powerhouse
-
Varroc Engineering Limited: From Polymer Components to a Global Automotive Systems Leader
-
Hitech Corporation Ltd - Prominent Manufacturer of Rigid Plastic Packaging Products, Serving Paints, Agrochemicals, Lubricants, FMCG, and Food Industries.
-
Mold-Tek Packaging Ltd – Leader in IML-Based Rigid Plastic Packaging Solutions
-
Bhansali Engineering Polymers Ltd. Expands Engineering Plastics Capacity in India
-
Styrenix Industries: Leading ABS & SAN Resin Producer in India
-
Chemplast Sanmar Ltd India’s Specialist PVC Resin & Paste PVC Manufacturer
-
BASF To Showcase Innovative and Sustainable Solutions at PlastIndia 2026
-
Essel Propack (EPL Limited): Engineering Multilayer Laminated Tube Packaging at Global Scale
-
Shaily Engineering Plastics: India’s Precision Plastics Partner to Global Med-Tech and Pharma Innovators
{{comment.DateTimeStampDisplay}}
{{comment.Comments}}